Titre:
  • Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
Auteur:Köhne, Claus Henning; De Greve, Jacques; Hartmann, Jörg Thomas; Lang, Istvan; Vergauwe, Philippe; Becker, K.-H.; Braumann, Dietrich; Joosens, E; Müller, Lutz Peter; Janssens, Jozef; Bokemeyer, C.; Reimer, Peter; Link, Hartmut; Späth-Schwalbe, Ernst; Wilke, Hansjochen Jochen; Bleiberg, Harry; Van den Brande, Jan; Debois, Marc; Bethe, Ullrich; Van Cutsem, Eric
Informations sur la publication:Annals of oncology, 19, 5, page (920-926)
Statut de publication:Publié, 2008-05
Sujet CREF:Cancérologie
Sciences bio-médicales et agricoles
Mots-clés:5-FU
Capecitabine
Celecoxib
Colorectal
First line
Irinotecan
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdm544
info:scp/43049126513